Clarification Regarding Potential Collaborations

March 28, 2023
Language flag

Scientific institutions like CERN and the US National Institute of Standards of Technology (NIST) actively seek to partner with academia and industry. Scientists from Phase Holographic Imaging (PHI) have met both institutions on several occasions to discuss the benefits of PHI’s non-invasive imaging technology within regenerative medicine and biomanufacturing. However, no partnerships have yet been established between PHI and these two institutions.

The above information is provided to mitigate any misinterpretation of the information unintentionally made publicly after a PHI presentation at a CERN Knowledge Transfer Seminar held on March 27, 2023. In the released information, it was stated that CERN and NIST are pending partners to PHI.

Links

Subscribe to PHI news on cision.com

Latest News

Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ) 14 March 2024

On Thursday, March 14, 2024, Phase Holographic Imaging PHI AB (publ), held an extraordinary general meeting. The following resolutions were passed at the meeting.
blue-cells_white-bg_banner

Shaping the future of Regenerative Medicine – PHI’s vision for QPI in Cell Therapy Manufacturing

PHI presents a comprehensive opinion piece detailing the versatility and potential the Company sees for Quantitative Phase Imaging (QPI) technology in Regenerative Medicine. PHI outlines how QPI will offer enhanced cell quality control in the cell manufacturing process, thereby addressing a central puzzle piece for making cell-based therapies safe, affordable, and accessible for all.
Altium_logo

New Distributor Partner Manager at Altium set to enhance global sales for PHI

PHI is conveying the news that its global distributor, Altium ., has appointed a PHI-dedicated distributor partner manager. This strategic step is set to significantly enhance the reach and sales performance of PHI’s HoloMonitor technology on a global scale.
See All News